Autonomic Modulation for Cardiovascular Disease
Author: Joseph Hadaya1,2,3, Jeffrey L Ardell1,2
Affiliation:
1 University of California, Los Angeles (UCLA) Cardiac Arrhythmia Center, David Geffen School of Medicine, Los Angeles, CA, United States.
2 UCLA Neurocardiology Research Program of Excellence, UCLA, Los Angeles, CA, United States.
3 Molecular, Cellular, and Integrative Physiology Program, UCLA, Los Angeles, CA, United States.
Conference/Journal: Front Physiol
Date published: 2020 Dec 22
Other:
Volume ID: 11 , Pages: 617459 , Special Notes: doi: 10.3389/fphys.2020.617459. , Word Count: 172
Dysfunction of the autonomic nervous system has been implicated in the pathogenesis of cardiovascular disease, including congestive heart failure and cardiac arrhythmias. Despite advances in the medical and surgical management of these entities, progression of disease persists as does the risk for sudden cardiac death. With improved knowledge of the dynamic relationships between the nervous system and heart, neuromodulatory techniques such as cardiac sympathetic denervation and vagal nerve stimulation (VNS) have emerged as possible therapeutic approaches for the management of these disorders. In this review, we present the structure and function of the cardiac nervous system and the remodeling that occurs in disease states, emphasizing the concept of increased sympathoexcitation and reduced parasympathetic tone. We review preclinical evidence for vagal nerve stimulation, and early results of clinical trials in the setting of congestive heart failure. Vagal nerve stimulation, and other neuromodulatory techniques, may improve the management of cardiovascular disorders, and warrant further study.
Keywords: arrhythmia; autonomic nervous system; heart failure; myocardial infaraction; neurocardiology; neuromodulation; sympathectomy; vagus nerve.
PMID: 33414727 PMCID: PMC7783451 DOI: 10.3389/fphys.2020.617459
BACK
